HK1070886A1 - Alkylammonium salts of omeprazole and esomeprazole - Google Patents

Alkylammonium salts of omeprazole and esomeprazole

Info

Publication number: HK1070886A1
Authority: HK; Hong Kong
Prior art keywords: sub; esomeprazole; omeprazole; salts; relates
Prior art date: 2002-03-05

Application number

HK05103451A

Other languages

English (en)

Inventor

Dahlstr M Mikael

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-05

Filing date

2005-04-21

Publication date

2005-06-30

2005-04-21 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2005-06-30 Publication of HK1070886A1 publication Critical patent/HK1070886A1/xx

Links

SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical class N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 title abstract 3
SUBDBMMJDZJVOS-DEOSSOPVSA-N esomeprazole Chemical class C([S@](=O)C1=NC2=CC=C(C=C2N1)OC)C1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-DEOSSOPVSA-N 0.000 title abstract 3
229960004770 esomeprazole Drugs 0.000 title abstract 3
229960000381 omeprazole Drugs 0.000 title abstract 3
125000005210 alkyl ammonium group Chemical group 0.000 title abstract 2
150000003839 salts Chemical class 0.000 abstract 3
150000001875 compounds Chemical class 0.000 abstract 2
-1 4-methoxy-3,5-dimethyl-2-pyridinyl Chemical group 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
150000003973 alkyl amines Chemical class 0.000 abstract 1
125000004122 cyclic group Chemical group 0.000 abstract 1
230000002496 gastric effect Effects 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Ceramic Engineering (AREA)
Manufacturing & Machinery (AREA)
Inorganic Chemistry (AREA)
Structural Engineering (AREA)
Health & Medical Sciences (AREA)
Materials Engineering (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Paper (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

HK05103451A 2002-03-05 2005-04-21 Alkylammonium salts of omeprazole and esomeprazole HK1070886A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US36218702P	2002-03-05	2002-03-05
PCT/SE2003/000378 WO2003074514A1 (en)	2002-03-05	2003-03-04	Alkylammonium salts of omeprazole and esomeprazole

Publications (1)

Publication Number	Publication Date
HK1070886A1 true HK1070886A1 (en)	2005-06-30

Family

ID=27789148

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK05103451A HK1070886A1 (en)	2002-03-05	2005-04-21	Alkylammonium salts of omeprazole and esomeprazole

Country Status (13)

Country	Link
US (1)	US7345061B2 (es)
EP (1)	EP1487818B1 (es)
JP (1)	JP4495465B2 (es)
AT (1)	ATE363480T1 (es)
AU (1)	AU2003208686A1 (es)
CA (1)	CA2474246C (es)
CY (1)	CY1108024T1 (es)
DE (1)	DE60314105T2 (es)
DK (1)	DK1487818T3 (es)
ES (1)	ES2286408T3 (es)
HK (1)	HK1070886A1 (es)
PT (1)	PT1487818E (es)
WO (1)	WO2003074514A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1633736A1 (en)	2003-05-05	2006-03-15	Ranbaxy Laboratories Limited	Barium salt of benzimidazole derivative
SE0302381D0 (sv)	2003-09-04	2003-09-04	Astrazeneca Ab	New salts I
SE0302382D0 (sv) *	2003-09-04	2003-09-04	Astrazeneca Ab	New salts II
CA2575718C (en)	2004-08-06	2010-12-14	Eisai R & D Management Co., Ltd.	Salts of benzimidazole derivative with amines and process for manufacturing the same
US7576219B2 (en)	2005-10-26	2009-08-18	Hanmi Pharm. Co., Ltd	Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
EP1801110A1 (en)	2005-12-22	2007-06-27	KRKA, tovarna zdravil, d.d., Novo mesto	Esomeprazole arginine salt
ES2355164T3 (es) *	2006-06-07	2011-03-23	Astrazeneca Ab	Nuevo método para la preparación de sales de amonio de esomeprazol.
WO2008092939A2 (en)	2007-01-31	2008-08-07	Krka, Tovarna Zdravil, D.D., Novo Mesto	Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic separation
KR20100042272A (ko)	2007-07-16	2010-04-23	아스트라제네카 아베	피리미딘 유도체 934
NZ593629A (en) *	2007-12-18	2012-11-30	Watson Pharma Private Ltd	Stable amorphous R-lansoprazole prepared by optically resolving racemic lansoprazole
NZ589150A (en) *	2008-05-14	2012-03-30	Watson Pharma Private Ltd	Stable r (+) -lansoprazole amine salt and a process for preparing the same
US8748619B2 (en) *	2009-11-12	2014-06-10	Hetero Research Foundation	Process for the resolution of omeprazole
CN110935190A (zh) *	2019-12-20	2020-03-31	达州瓮福蓝剑化工有限责任公司	一种铵盐连续结晶工艺及装置

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE7804231L (sv)	1978-04-14	1979-10-15	Haessle Ab	Magsyrasekretionsmedel
SE8301182D0 (sv) *	1983-03-04	1983-03-04	Haessle Ab	Novel compounds
GB2189698A (en)	1986-04-30	1987-11-04	Haessle Ab	Coated omeprazole tablets
FR2692146B1 (fr) *	1992-06-16	1995-06-02	Ethypharm Sa	Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
SE9301830D0 (sv)	1993-05-28	1993-05-28	Ab Astra	New compounds
KR100384960B1 (ko) *	1994-07-08	2003-08-21	아스트라제네카 악티에볼라그	다단위정제투여형i
SE504459C2 (sv) *	1994-07-15	1997-02-17	Astra Ab	Förfarande för framställning av substituerade sulfoxider
SE508669C2 (sv) *	1996-04-26	1998-10-26	Astra Ab	Nytt förfarande
SE510650C2 (sv)	1997-05-30	1999-06-14	Astra Ab	Ny förening
US6048981A (en) *	1998-04-22	2000-04-11	Torcan Chemical Ltd.	Magnesium omeprazole and process for its preparation

2003
- 2003-03-04 DE DE60314105T patent/DE60314105T2/de not_active Expired - Lifetime
- 2003-03-04 CA CA2474246A patent/CA2474246C/en not_active Expired - Fee Related
- 2003-03-04 US US10/506,345 patent/US7345061B2/en not_active Expired - Fee Related
- 2003-03-04 AT AT03707279T patent/ATE363480T1/de active
- 2003-03-04 AU AU2003208686A patent/AU2003208686A1/en not_active Abandoned
- 2003-03-04 EP EP03707279A patent/EP1487818B1/en not_active Expired - Lifetime
- 2003-03-04 PT PT03707279T patent/PT1487818E/pt unknown
- 2003-03-04 JP JP2003572982A patent/JP4495465B2/ja not_active Expired - Fee Related
- 2003-03-04 ES ES03707279T patent/ES2286408T3/es not_active Expired - Lifetime
- 2003-03-04 DK DK03707279T patent/DK1487818T3/da active
- 2003-03-04 WO PCT/SE2003/000378 patent/WO2003074514A1/en active IP Right Grant
2005
- 2005-04-21 HK HK05103451A patent/HK1070886A1/xx not_active IP Right Cessation
2007
- 2007-07-20 CY CY20071100973T patent/CY1108024T1/el unknown

Also Published As

Publication number	Publication date
CA2474246C (en)	2010-06-29
JP2005521693A (ja)	2005-07-21
US20050182099A1 (en)	2005-08-18
WO2003074514A1 (en)	2003-09-12
EP1487818B1 (en)	2007-05-30
DE60314105T2 (de)	2008-01-24
ATE363480T1 (de)	2007-06-15
DK1487818T3 (da)	2007-08-20
DE60314105D1 (de)	2007-07-12
EP1487818A1 (en)	2004-12-22
US7345061B2 (en)	2008-03-18
CA2474246A1 (en)	2003-09-12
ES2286408T3 (es)	2007-12-01
PT1487818E (pt)	2007-07-18
CY1108024T1 (el)	2013-09-04
AU2003208686A1 (en)	2003-09-16
JP4495465B2 (ja)	2010-07-07

Legal Events

Date	Code	Title	Description
2012-10-12	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20120304

Publication	Publication Date	Title
HK1070886A1 (en)	2005-06-30	Alkylammonium salts of omeprazole and esomeprazole
US6150380A (en)	2000-11-21	Crystalline form of omeprazole
AU2003289948B2 (en)	2009-12-24	Process for preparing optically pure active compounds
SE9900274D0 (sv)	1999-01-28	New compound
EP1861391B1 (en)	2011-10-12	Methods for preparing substituted sulfoxide compounds
IL168554A (en)	2011-06-30	Process for preparing s-pantoprazole
HUP0303928A2 (hu)	2004-03-01	Omeprazol kristályos formája, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények
SE0302382D0 (sv)	2003-09-04	New salts II
SE0302381D0 (sv)	2003-09-04	New salts I
US20070225500A1 (en)	2007-09-27	Process for the Preparation of Pyridin-2-Ylmethylsulphinyl-1H-Benzimidazol Compounds
YU32301A (sh)	2005-07-19	Novi kristalni oblik omeprazola
MY118724A (en)	2005-01-31	New crystalline form of omeprazole
MXPA01004651A (es)	2002-06-05	Nueva forma cristalina de omeprazol
MXPA01007516A (es)	2002-05-09	Sal de potasio de (s)-omeprazol
KR20070031945A (ko)	2007-03-20	피리딘-2-일메틸설피닐-1ｈ-벤즈이미다졸 화합물의 제조방법